Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice

Human Molecular Genetics

Volumn 16, Issue 23, 2007, Pages 2900-2910

  Yang, Wonsuk ^a   Chen, Linan ^a   Ding, Yunmin ^a   Zhuang, Xiaoxi ^a   Kang, Un Jung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; DJ 1 PROTEIN; DOPAMINE; PARAQUAT; PROTEASOME; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SIMULATION; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME DEFECT; GENETIC SUSCEPTIBILITY; HEREDITY; MALE; MESENCEPHALON; MOTOR DYSFUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; UBIQUITINATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN; DOPAMINE; HERBICIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; ONCOGENE PROTEINS; PARAQUAT; PARKINSONIAN DISORDERS; PROTEASOME ENDOPEPTIDASE COMPLEX; PSYCHOMOTOR PERFORMANCE; UBIQUITINATION;

MUS;

EID: 35748954034     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm249     Document Type: Article

References (70)

1. de Rijk, M.C., Breteler, M.M., Graveland, G.A., Ott, A., Grobbee, D.E., vah der Meche, F.G. and Hofman, A. (1995) Prevalence of Parkinson's disease in the elderly: The Rotterdam Study. Neurology, 45, 2143-2146.
2. Wood-Kaczmar, A., Gandhi, S. and Wood, N.W. (N06) Understanding the molecular causes of Parkinson's disease. Trends Mol. Med., 12 521-528.
3. Lang, A.E. and Lozano, A.M. (1998) Parkinson's disease. Second of two parts. N. Engl. J. Med., 339, 1130-1143.
4. Forno, L.S. (1996) Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol., 55, 259-272.
5. Hertzman, C., Wiens, M., Bowering, D., Snow, B. and Calne, D. (1990) Parkinson's disease: A case-control study of occupational and environmental risk factors. Am. J. Ind. Med., 17, 349-355.
6. Liou, H.H., Tsai, M.C., Chen, C.J., Jeng, J.S., Chang, Y.C., Chen, S.Y. and Chen, R.C. (1997) Environmental risk factors and Parkinson's disease: A case-control study in Taiwan. Neurology, 48, 1583-1588.
7. Sanchez-Ramos, J.R., Hefti, F. and Weiner, W.J. (1987) Paraquat and Parkinson's disease. Neurology, 37, 728.
8. Liou, H.H., Chen, R.C., Tsai, Y.F., Chen, W.P., Chang, Y.C. and Tsai, M.C. (1996) Effects of paraquat on the substantia nigra of the Wistar rats: Neurochemical, histological, and behavioral studies. Toxicol. Appl. Pharmacol., 137, 34-41.
9. McCormack, A.L., Thiruchelvam, M., Manning-Bog, A.B., Thiffault, C., Langston, J.W., Cory-Slechta, D. and Di Monte, D.A. (2002) Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis., 19, 119-127.
10. McCormack, A.L., Atienza, J.G., Johnston, L.C., Andersen, J.K., Vu, S. and Di Monte, D.A. (2005) Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem., 93, 1030-1037.
11. Manning-Bog, A.B., McCormack, A.L., Li, J., Uversky, V.N., Fink, A.L. and Di Monte, D.A. (2002) The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice. J. Biol. Chem., 277 1641-1644.
12. Tao, X. and Tong, L. (2003) Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. J. Biol. Chem., 278, 31372-31379.
13. Bonifati, V., Oostra, B.A. and Heutink, P. (2004) Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease. J. Mol. Med., 82, 163-174.
14. Bandopadhyay, R., Kingsbury, A.E., Cookson, M.R., Reid, A.R., Evans, I.M., Hope, A.D., Pittman, A.M., Lashley, T., Canet-Aviles, R., Miller, D.W. et al. (2004) The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain, 127, 420-430.
15. Nagakubo, D., Taira, T., Kitaura, H., Iked a, M., Tamai, K., Iguchi-Ariga, S.M. and Ariga, H. (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun., 231, 509-513.
16. Taira, T., Saito, Y., Niki, T., Iguchi-Asiga, S.M., Takahashi, K. and Ariga, H. (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep., 5, 213-218.
17. Takahashi, K., Taira, T., Niki, T., Seino, C., Iguchi-Ariga, S.M. and Ariga, H. (2001) DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276, 37556-37563.
18. Xu, J., Zhong, N., Wang, H., Elias, J.E., Kim, C.Y., Woldman, I., Pifl, C., Gygi, S.P., Geula, C. and Yankner, B.A. (2005) The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum. Mol. Genet., 14, 1231-1241.
19. Zhong, N., Kim, C.Y., Rizzu, P., Geula, C., Porter, D.R., Pothos, E.N., Squitieri, F., Heutink P. and Xu, J. (2006) DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J. Biol. Chem., 281, 20940-20948.
20. Martinat, C., Shendelman, S., Jonason, A., Leete, T., Beal, M.F., Yang, L., Floss, T. and Abeliovich, A. (2004) Sensitivity to oxidative stress in DJ-1 -deficient dopamine neurons: An ES- derived cell model of primary Parkinsonism. PLoS Biol., 2, e327.
21. Yokota, T., Sugawara, K., Ito, K., Takahashi, R., Ariga, H. and Mizusawa, H. (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem. Blophys. Res. Commun., 312, 1342-1348.
22. Shendelman, S., Jonason, A., Martinat, C., Leete, T. and Abeliovich, A. (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol., 2, e362.
23. Zhou, W. and Freed, C.R. (2005) DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J. Biol. Chem., 280, 43150-43158.
24. DeMartino, G.N. and Slaughter, C.A. (1999) The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem., 274 22123-22126.
25. Tanaka, K. and Chiba, T. (1998) The proteasome: A protein-destroying machine. Genes Cells, 3, 499-510.
26. de Vrij, F.M., Fischer, D.F., van Leeuwen, F.W. and Hol, E.M. (2004) Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog. Neurobiol., 74, 249-270.
27. Goldberg, A.L. (2003) Protein degradation and protection against misfolded or damaged proteins. Nature, 426, 895-899.
28. Sherman, N.Y. and Goldberg, A.L. (2001) Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron, 29, 15-32.
29. Chung, K.K., Dawson, V.L. and Dawson, T.M. (2001) The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci. Suppl., 24, S7-S14.
30. McNaught, K. S. and Jenner, P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett., 297, 191-194.
31. McNaught, K,S., Belizaire, R., Jenner, P., Olanow, CW. and Isacson, O. (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett., 326, 155-158.
32. McNaught, K.S., Belizaire, R., Isacson, O., Jenner, P. and Olanow, C.W. (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol., 179, 38-46.
33. Chen, L., Cagniard, B., Mathews, T., Jones, S., Koh, H.C., Ding, Y., Carvey, P.M., Ling, Z., Kang, U.J. and Zhuang, X. (2005) Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J. Biol. Chem., 280, 21418-21426.
34. Brooks, A.I., Chadwick, H.A., Gelbard, D.A., Cory-Slechta, D.A. and Federoff, H.J. (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res., 823, 1-10.
35. Thiruchelvam, M., Richfield, E.K., Baggs, R.B., Tank, A.W. and Cory-Slechta, D.A. (2000) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson's disease. J. Neurosci., 20 9207-9214.
36. Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D.A., Richfield, E.K., Buckley, B. and Mirochnitchenko, O. (2005) Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J. Biol. Chem., 280 22530-22539.
37. Dick, T.P., Nussbaum, A.K., Deeg, M., Heinemeyer, W., Groll, M., Schirle, M., Keilholz, W., Stevanović, S., Wolf, D.H. Huber, R. et al. (1998) Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem., 273, 25637-25646.
38. Hyun, D.H., Gray, D.A., Halliwell, B. and Jenner, P. (2004) Interference with ubiquitination causes oxidative damage and increased protein nitration: Implications for neurodegenerative diseases. J. Neurochem. 90, 422-430.
39. Rideout, H.J. and Stefanis, L. (2002) Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination. Mol. Cell Neurosci., 21, 223-238.
40. Smith, D.M., Benarondj, N. and Goldberg, A. (2006) Proteasomes and their associated ATPases: A destructive combination. J. Struct. Biol., 156, 72-83.
41. Höglinger, G.U., Carrard, G., Michel, P.P., Medja, F., Lombès, A., Ruberg, M., Friguet, B. and Hirsch, E.C. (2003) Dysfunction of mitochondrial complex I and the proteasome: Interactions between two biochemical deficits in a cellular model of Parkinson's disease. J. Neurochem., 86, 1297-1307.
42. McNaught, K.S., Jackson, T., JnoBaptiste, R., Kapustin, A. and Olanow, C.W. (2006) Proteasomal dysfunction in sporadic Parkinson's disease. Neurology, 66, S37-S49.
43. Ishii, T., Sakurai, T., Usami, H. and Uchida, K. (2005) Oxidative modification of proteasome: Identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry, 44, 13893-13901.
44. Groll, M., Heinemeyer, W., Jäger, S., Ullrich, T., Bochtler, M., Wolf, D.H. and Huber, R. (1999) The catalytic sites of 20S proteasomes and their role in subunit maturation: A mutational and crystallographic study. Proc. Natl. Acad. Sci. USA, 96, 10976-10983.
45. Li, Z., Arnaud, L., Rockwell, P. and Figueiredo-Pereira, M.E. (2004) A single amino acid substitution in a proteasome 'subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells. J. Neurochem., 90, 19-28.
46. Kwak, M.K. and Kensler, T.W. (2006) Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthere through the Nrf2-ARE, but not the AhR/Amt-XRE, pathway. Biochem. Biophys. Res. Commun., 345, 1350-1357.
47. Kensler, T.W., Wakabayashi, N. and Biswal, S. (2007) Cell survival responses to environmental stresses via the Keapl-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol., 47, 89-116.
48. Clements, C.M., McNally, R.S., Conti, B.J., Mak, T.W. and Ting, J.P. (2006) DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl Acad Sci. USA, 103, 15091-15096.
49. Goldberg, M.S., Pisani, A., Haburcak, M., Vortherms, T.A., Kitada, T., Costa, C., Tong, Y., Martella, G., Tscherter, A., Martins, A. et al. (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1. Neuron 45, 489-496.
50. Barnham, K.J., Masters, C.L. and Bush, A.I. (2004) Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov., 3, 205-214.
51. Ciechanover, A. and Brundin, P. (2003) The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg. Neuron, 40, 427-446.
52. McNaught, K.S. and Olanow, C.W. (2006) Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease. Neurobiol. Aging, 27, 530-545.
53. McNaught, K.S., Perl, D.P., Brownell, A.L. and Olanow, C.W. (2004) Systemic exposure to proteasorne inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol., 56, 149-162.
54. Gomez, C., Bandez, M.J. and Navarro, A. (2007) Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. Front Biosci., 12, 1079-1093.
55. Inden, M., Taira, T., Kitamura, Y., Yanagida, T., Tsuchiya, D., Takata, K., Yanagisawa, D., Nishimura, K., Taniguchi, T., Kiso, Y. et al. (2006) PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol. Dis., 24 144-158.
56. Li, H.M., Taira, T., Maita, C., Ariga, H. and Iguchi-Ariga, S.M. (2007) Protection against nonylphenol-induced cell death by DJ-1 in cultured Japanese medaka (Oryzias latipes) cells. Toxicology, 228 229-238.
57. Menzies, F.M., Yenisetti, S.C. and Min, K.T. (2005) Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr. Biol., 15, 1578-1582.
58. Ooe, H., Taira, T., Iguchi-Ariga, S.M. and Ariga, H. (2005) Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol. Sci, 88, 114-126.
59. Yang, Y., Gehrke, S., Haque, M.E., Imai, Y., Kosek, J., Yang, L., Beal, M.F., Nishimura, I., Wakamatsu, K., Ito, S. et al. (2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. USA, 102, 13670-13675.
60. Hirata, Y. and Nagatsu, T. (2005) Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slices. Toxicology, 216 9-14.
61. Sherer, T.B., Betarbet, R., Testa, C.M., Seo, B.B., Richardson, J.R., Kim, J.H., Miller, G.W., Yagi, T., Matsuno-Yagi, A. and Greenamyre, J.T. (2003) Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci., 23, 10756-10764.
62. Maracchioni, A., Totaro, A., Angelini, D.F., Di Penta, A., Bernardi, G., Card, M.T. and Achsel, T. (2007) Mitochondrial damage modulates alternative splicing in neuronal cells: Implications for neurodegeneration. J. Neurochem., 100, 142-153.
63. Zhang, L., Shimoji, M., Thomas, B., Moore, D.J., Yu, S.W., Marupudi, N.I., Torp, R., Torgner, I.A., Ottersen, O.P., Dawson, T.M. et al. (2005) Mitochondrial localization of the Parkinson's disease related protein DJ-1: Implications for pathogenesis. Hum. Mol. Genet., 14, 2063-2073.
64. Canet-Avilés, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M.J., Ringe, D., Petsko, G.A. and Cookson, M.R. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA, 101, 9103-9108.
65. Betarbet, R., Canet-Aviles, R.M., Sherer, T.B., Mastroberardino, P.G., McLendon, C., Kim, J.H., Lund, S., Na, H.M., Taylor, G., Bence, N.F. et al. (2006) Intersecting,pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol. Dis. 22, 404-420.
66. Shamoto-Nagai, M., Maruyama, W., Akao, Y., Osawa, T., Tribl, F., Gerlach, M., Zucca, F.A., Zecca, L., Riederer, P. and Naoi, M. (2004) Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells. J. Neural. Transm., 111, 1253-1265.
67. Franklin, K.B. and Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, USA.
68. Ding, Y.M., Jaumotte, J.D., Signore, A.P. and Zigmond, M.J. (2004) Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J. Neurochem., 89, 776-787.
69. Zeng, B.Y., Iravani, M.M., Lin, S.T., Irifune, M., Kuoppamäki, M., A1-Barghouthy, G., Smith, L., Jackson, M.J., Rose, S., Medhurst, A.D. et al. (2006) MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome. Eur. J. Neurosci., 23, 1766-1774.
70. Abrahams, M.R., Zhang, Z., Chien, S., Skerns, T. and Kotwal, G.J. (2005) The vaccinia virus N1L ORF may encode a multifunctional protein possibly targeting different kinases, one of which influences ATP levels in vivo. Ann. N. Y. Acad. Sci., 1056, 87-99.